Correlation Between Travere Therapeutics and Terns Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Travere Therapeutics and Terns Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Travere Therapeutics and Terns Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Travere Therapeutics and Terns Pharmaceuticals, you can compare the effects of market volatilities on Travere Therapeutics and Terns Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Travere Therapeutics with a short position of Terns Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Travere Therapeutics and Terns Pharmaceuticals.
Diversification Opportunities for Travere Therapeutics and Terns Pharmaceuticals
-0.44 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Travere and Terns is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Travere Therapeutics and Terns Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Terns Pharmaceuticals and Travere Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Travere Therapeutics are associated (or correlated) with Terns Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Terns Pharmaceuticals has no effect on the direction of Travere Therapeutics i.e., Travere Therapeutics and Terns Pharmaceuticals go up and down completely randomly.
Pair Corralation between Travere Therapeutics and Terns Pharmaceuticals
Given the investment horizon of 90 days Travere Therapeutics is expected to generate 1.33 times more return on investment than Terns Pharmaceuticals. However, Travere Therapeutics is 1.33 times more volatile than Terns Pharmaceuticals. It trades about 0.14 of its potential returns per unit of risk. Terns Pharmaceuticals is currently generating about -0.34 per unit of risk. If you would invest 1,456 in Travere Therapeutics on August 25, 2024 and sell it today you would earn a total of 369.00 from holding Travere Therapeutics or generate 25.34% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Travere Therapeutics vs. Terns Pharmaceuticals
Performance |
| Timeline |
| Travere Therapeutics |
| Terns Pharmaceuticals |
Travere Therapeutics and Terns Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Travere Therapeutics and Terns Pharmaceuticals
The main advantage of trading using opposite Travere Therapeutics and Terns Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Travere Therapeutics position performs unexpectedly, Terns Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Terns Pharmaceuticals will offset losses from the drop in Terns Pharmaceuticals' long position.| Travere Therapeutics vs. Eliem Therapeutics | Travere Therapeutics vs. HCW Biologics | Travere Therapeutics vs. Scpharmaceuticals | Travere Therapeutics vs. Milestone Pharmaceuticals |
| Terns Pharmaceuticals vs. Capricor Therapeutics | Terns Pharmaceuticals vs. Akari Therapeutics PLC | Terns Pharmaceuticals vs. Soleno Therapeutics | Terns Pharmaceuticals vs. Bio Path Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Complementary Tools
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |